Suppr超能文献

PspA,一种可引发保护性免疫的肺炎球菌蛋白:分离出的天然PspA在小鼠体内的免疫原性。

PspA, a protection-eliciting pneumococcal protein: immunogenicity of isolated native PspA in mice.

作者信息

Briles D E, King J D, Gray M A, McDaniel L S, Swiatlo E, Benton K A

机构信息

Department of Microbiology, University of Alabama at Birmingham 35294-2170, USA.

出版信息

Vaccine. 1996 Jun;14(9):858-67. doi: 10.1016/0264-410x(96)82948-3.

Abstract

PspA is a surface exposed virulence factor of S. pneumoniae that can elicit protective immunity to pneumococcal sepsis in mice. It can be released from pneumococci by washing them with a solution containing 2% choline chloride, by growing pneumococci in media containing 1.2% choline chloride, or by growing pneumococci in media in which the choline has been replaced by ethanolamine. Our results indicate that PspA is the major protection-eliciting antigen in each of these preparations. Two injections of < or = 1 microgram of native PspA purified by use of a choline-Sepharose column are highly immunogenic in BALB/c and CBA/N mice, and even in the absence of adjuvant can elicit protection against otherwise fatal sepsis with 100 times the LD50 of S. pneumoniae. Fragments comprising the N-terminal 115 and 245 amino acids of PspA were able to elicit protection but only in the presence of complete Freund's adjuvant (CFA). In the absence of CFA the 245 amino acid fragment was less than 1/100 as immunogenic as native PspA.

摘要

肺炎球菌表面蛋白A(PspA)是肺炎链球菌的一种表面暴露毒力因子,可在小鼠中引发针对肺炎球菌败血症的保护性免疫。通过用含2%氯化胆碱的溶液洗涤肺炎球菌、在含1.2%氯化胆碱的培养基中培养肺炎球菌或在胆碱被乙醇胺替代的培养基中培养肺炎球菌,均可从肺炎球菌中释放出PspA。我们的结果表明,PspA是这些制剂中每种制剂的主要引发保护作用的抗原。两次注射经胆碱-琼脂糖柱纯化的≤1微克天然PspA,在BALB/c和CBA/N小鼠中具有高度免疫原性,甚至在无佐剂的情况下,也能引发针对肺炎链球菌100倍半数致死量(LD50)的致命败血症的保护作用。包含PspA N端115和245个氨基酸的片段能够引发保护作用,但仅在完全弗氏佐剂(CFA)存在的情况下。在无CFA时,245个氨基酸的片段免疫原性不到天然PspA的1/100。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验